Miti Saksena

MedicineAgricultural and Biological SciencesImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron”.

Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron

Nature(2021)10.1038/s41586-022-04399-5

N/A

0DataRank · unranked

533 citations

Hala Alshammary, Johnstone Tcheou, Gagandeep Singh, Ariel Raskin, Hisaaki Kawabata +38 more

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation

The Lancet Microbe(2021)10.1016/s2666-5247(21)00068-9

N/A

0DataRank · unranked

436 citations

Chengjin Ye, Raveen Rathnasinghe, Daniel Stadlbauer, Hala Alshammary, Angela A. Amoako +25 more

SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2

Cell(2021)10.1016/j.cell.2021.06.005

N/A

0DataRank · unranked

313 citations

Mahima Thapa, Tinting Lei, Shaza M. Sayed Ahmed, Daniel C. Adelsberg, Juan Manuel Carreño +42 more

Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma

Cancer Cell(2021)10.1016/j.ccell.2021.06.014

N/A

0DataRank · unranked

217 citations

Charles Gleason, Sarita Agte, Komal Srivastava, Katherine F. Beach, Adolfo Aleman +27 more

Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma

Cancer Cell(2021)10.1016/j.ccell.2021.09.015

N/A

0DataRank · unranked

76 citations

Bhaskar Upadhyaya, Kevin Tuballes, Katerina Kappes, Charles Gleason, Katherine F. Beach +37 more

Reduced neutralizing activity of post-SARS-CoV-2 vaccination serum against variants B.1.617.2, B.1.351, B.1.1.7+E484K and a sub-variant of C.37

medRxiv(2021)10.1101/2021.07.21.21260961

N/A

0DataRank · unranked

18 citations

Hala Alshammary, Gagandeep Singh, Ariel Raskin, Fatima Amanat, Angela A. Amoako +36 more

SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals

Nature Communications(2022)10.1038/s41467-022-32389-8

N/A

0DataRank · unranked

168 citations

Disha Bhavsar, Gagandeep Singh, Daniel Floda, Komal Srivastava, Charles Gleason +25 more

Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera

Nature Communications(2022)10.1038/s41467-022-30763-0

N/A

0DataRank · unranked

42 citations

Sonia Jangra, Chengjin Ye, Anastasija Čupić, Gagandeep Singh, Carles Martínez‐Romero +43 more

Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients

Cancer Cell(2022)10.1016/j.ccell.2022.03.013

N/A

0DataRank · unranked

38 citations

Oliver Van Oekelen, Bhaskar Upadhyaya, Katherine F. Beach, Ariel Kogan Zajdman, Hala Alshammary +43 more

SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase

Immunity(2024)10.1016/j.immuni.2024.01.017

N/A

0DataRank · unranked

144 citations

Juan Manuel Carreño, Charles Gleason, Brian Monahan, Gagandeep Singh, Anass Abbad +48 more